EM12-SO2F is a potent covalent CRBN inhibitor, binding at His353 to modulate protein interactions. It serves as a valuable probe for CRBN research and effectively blocks lenalidomide-induced IKZF1 degradation in MOLT4 cells, offering insights into targeted protein regulation.
Usually ships within 24 hours.